Abstract: Serum and membrane proteins are two of the most attractive targets for proteomic analysis. Previous membrane protein studies tend to focus on tissue sample, while membrane protein studies in serum are still limited. In this study, an analysis of membrane proteins in normal human serum was carried out. Nano-liquid chromatography-electrospray ionization mass spectrometry (NanoLC-ESI-MS/MS) and bioinformatics tools were used to identify membrane proteins. Two hundred and seventeen membrane proteins were detected in the human serum, of which 129 membrane proteins have at least one transmembrane domain (TMD). Further characterizations of identified membrane proteins including their subcellular distributions, molecular weights, post translational modifications, transmembrane domains and average of hydrophobicity, were also implemented. Our results showed the potential of membrane proteins in serum for diagnosis and treatment of diseases.
Introduction
As the most easily obtained sample from patients, blood plasma is the primary specimen used to diagnose and monitor many diseases. Because changes in certain components of the plasma are indicative of abnormalities in the body system, many researches have been carried out in search for disease biomarkers in the plasma since the early history of clinical study. After proteomics emerged as a major discipline at the end of the 20th century, plasma study was launched in this new research direction, which could potentially analyze hundreds of proteins at the same time, instead of the one-protein study allowed by traditional genetic/ biochemical approach.
The plasma contains thousands of proteins, including those originating from most, if not all kinds of cells and tissues. 1 The plasma is considered one of the most promising proteomes for proteomic research, and many proteomic techniques and methods have been utilized and modified to analyze the human plasma. 2 In an early study of human plasma, Pieper et al could identify 325 proteins using two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS). 3 Advancements in the field of proteomics in the past decade have assisted plasma studies in both breadth and depth, exemplified by the forming of a human plasma Peptide Atlas by researchers participating in the Plasma Proteome Project of the Human Proteome Organization (HUPO). 4 Comparative studies of the plasma have revealed many potential markers and some insights into the mechanisms of tissue specific diseases, such as cancers, 5 Alzheimer's disease, 6 and myocardial infarction. 7 Membrane proteomics is a highly focused branch of proteomics. Approximately 30% of proteins encoded by the mammalian genome are transmembrane proteins. 8, 9 Membrane proteins play an important part in many important cellular processes, including cross-membrane transportation, cell adhesion, signal transduction, immune response, etc. 10 Due to their roles as transporters, receptors and structural proteins as well as their impacts on intracellular processes, they are the usual candidates for drug development: about 60% of approved drugs target membrane proteins. 11 Many membrane proteins were also found to directly associate with various human diseases, such as Alzheimer's disease, diabetes, Hodgkin's disease and liver cirrhosis. 12 Thus, researches on membrane proteins also hold promises for developments of diagnosis and disease treatment.
The recent studies on human and mammalian membrane proteins tend to focus on cell/tissue samples. [13] [14] [15] Using carbonate extraction, trypsin digestion and NanoLC-MS/MS, a multilaboratory project has been found to profile membrane proteins from mouse liver. 16, 17 Another study based on similar approaches, more than 200 proteins were detected in pancreatic cancer cells. 18 Furthermore, a large number (862) of membrane proteins were identified in the brain cortex. 19 However, we have not found any independent research that focus only on membrane proteins in serum. As a subset of the plasma, serum contains thousands of proteins, including the proteins of membrane origin, even though their abundance can be low. In this study, some results of profiling and characterization of membrane proteins in human serum by using combination of NanoLC-ESI-MS/MS methods and bioinformatics tools are shown. The present study was approved by the Ethics Committee of the Institute of Biotechnology (IBT), Vietnam Academy of Science and Technology (VAST).
Materials and Methods Materials
Dithiothreitol (DTT), iodoacetamide (IAA), ammonium bicarbonate, ammonium acetate, trypsin (pro teomics sequencing grade), sodium bicarbonate and Triton X-100 were purchased from Sigma-Aldrich (St. Louis, MO, USA). Formic acid (FA) and triflouracetate (TFA) were obtained from Fluka (Fluka Chemie GmbH, Buchs, Switzerland). Acetonitrile (ACN, chromatogram grade) and other chemicals (analytical grade) were obtained from Barker (Pittsburgh, USA). The Bradford assay kit, Aurum serum protein mini kit, acrylamide, bis-acrylamide, urea, glycine, Tris, CHAPS, and SDS were purchased from Bio-Rad (Hercules, CA, USA). All equipment and standard reagents used directly should be clean as necessary.
Sample preparation
Sera from healthy middle-aged individuals (20-40 years old) were supplied by Bach Mai Hospital, Hanoi, Vietnam, and stored at −80 °C until analysis. After that, albumin and IgG were depleted from the samples using the Aurum serum protein mini kit (Bio-Rad Laboratories, Hercules, CA, USA). Briefly, serum protein column was washed with 1 ml of serum protein binding buffer. For each sample, 60 µl of serum was diluted with 180 µl serum protein binding buffer and then, 200 µl of diluted serum was loaded onto the column. Subsequently, the depleted serum -unbound fraction was collected by centrifugation at 10,000 × g for 20 sec. The removal of albumin and IgG was evaluated by 12.6% SDS-PAGE.
In-solution trypsin digestion
The depleted sera containing approximately 30 µg of total protein were dried by vacuum centrifugation and then dissolved in 50 mM NH 4 HCO 3 . The samples were reduced by 10 mM dithiothreitol (DTT) at 56 °C for 30 min and alkylated by 5 mM iodoacetamide (IAA) at room temperature for 1 hr. Proteins in the samples were digested using trypsin (Sequencing grade, Sigma-Aldrich, St. Louis, MO, USA) at ratio of 1:50 (w/w) enzyme to protein at 37 °C for 12 hrs. The digestion was stopped by formic acid with final concentration of 0.1%. nano two-dimensional chromatography and mass spectrometry Tryptic peptides were dissolved in 0.1% formic acid and loaded onto Strong Cation Exchange (SCX) Chromatography Column (LC Packing, Dionex, The Netherlands) for separation in the first dimension. The second dimension was performed using a C18 Reversed Phase (RP) Column (GraceVydac, Hesperia, CA, USA) with mobile phase consisting of 0.1% formic acid in water (A) and 0.1% formic acid in 85% acetonitrile (B). Peptides were eluted in a linear gradient from 0% to 100% mobile phase B at a flow rate of 0.2 µl/min for 90 min.
Tandem mass spectrometry analysis were performed using an ABI QSTAR ® XL hybrid quadrupole/TOF MS/MS instrument (Applied Biosystems/MDS Sciex, Ontario, Canada) equipped with a nanoelectrospray source (Protana XYZ manipulator). Positive mode nanoelectrospray was generated from fused-silica PicoTip emitters with a 10 µm aperture (New Objective, Woburn, MA) at 2.5 kV. MS and MS/MS spectra were recorded and processed in IDA mode (Information Dependent Acquisition) controlled by Analyst QS software. The range of the MS full scan was from 200 to 1500 amu followed by MS/MS fragmentation of the three most intense precursor ions. The dynamic ion selection threshold for MS/MS experiments was set to 45 counts.
Identification of membrane proteins
The obtained MS and MS/MS spectra were searched against the NCBInr and the Swiss-Prot protein sequence database using Mascot TM V1.8 software (Matrix Science Ltd., London, UK). The parameters for searching were set as following: enzymatic digestion with trypsin with one potential missed cleavage; a peptide and fragment mass tolerance of ±0.5; carbamidomethyl (cysteine) as fixed modification; oxidation (methionine) as variable modification. Protein identifications were performed using a Mowse scoring algorithm with a confidence level of 95% and with at least two matched peptides. Membrane proteins were sorted from total identified serum proteins based on UniProt protein database (http://www.uniprot.org). SOSUI prediction algorithm was used to predict transmembrane domains and average values of hydrophobicity of those membrane proteins.
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Results
Identification of membrane proteins in serum
The major aim of this study is to detect and profile membrane proteins from human serum. With the strategy and methods described above, 217 membrane proteins were detected from 2778 matched peptides (see Table 1 , Supplementary Data). It is interesting to note that more than 90% of the identifications were based on 3 or more matched peptides. From the total of 217 identified membrane proteins, 129 proteins have at least one transmembrane domain (TMD) based on SOSUI prediction algorithm (see Table 1 , Supplementary Data).
evaluation of membrane protein molecular weight
The distribution of molecular weights of membrane proteins from serum was shown in Figure 1 . Membrane proteins in serum have a wide range of molecular weights. Proteins with molecular weights from 100-200 kDa make up the largest group, accounting for 43% the total of 217 identified membrane proteins. The second most abundant is the group of proteins with molecular weights in the range of 200-300 kDa (26%). It is also notable that several membrane proteins (6%) have molecular weights above 500 kDa.
Transmembrane domains (TMDs) and average of hydrophobicity TMD is one of the most distinguished features of membrane proteins. In our study, 129 (59.4%) proteins were predicted to have at least one TMD in the total of 217 membrane proteins according to SOSUI prediction algorithm. The majority of these 129 proteins have one TMD (25 proteins) and two TMDs (40 proteins), but a considerable number have more than 8 TMDs, which are often receptors, transporters or ion channels.
In this study, SOSUI prediction algorithm was also used to evaluate the hydrophobicity of membrane proteins from human serum. The average hydrophobicity values of all identified membrane proteins were calculated based on their amino acid sequences. It is notable that almost all proteins have average hydrophobicity values below zero. Only 17 proteins have positive average hydrophobicity values and most of them (16 proteins) are integral membrane proteins or transmembrane proteins. In addition, 7 UniProt annotated membrane proteins could not be analyzed by SOSUI prediction algorithm because their sizes have more than 5000 amino acids.
Subcellular distribution of membrane proteins
The subcellular distribution of 217 identified membrane proteins was determined using UniProt database according to their accession numbers. Analyzing the available information about the identified membrane proteins, we found that, these proteins have a certain distribution or are shuttled between organelles: 119 proteins are from plasma membrane and a range of proteins are from other cell components, such as nucleus (11 proteins), endoplasmic reticulum (16 proteins), Golgi apparatus (23 proteins), and mitochondrion (7 proteins).
Post-translational modifications of membrane proteins
In this study, 359 post-translational modifications (PTMs) of membrane proteins were found in 187 proteins based on UniProt database; the other 30 membrane proteins do not have post translational modifications. Among the total of membrane proteins having PTMs, proteins with one PTM (77 proteins -41.2%) and two PTMs (66 proteins -35.3%) are the majority, while proteins with 5 PTMs make up the smallest group (4 proteins -2.1%).
Among 359 modifications found in the identified membrane proteins, phosphorylation was the most common modification, with 136 phosphoproteins. Follow-up was glycosylation, with 96 glycoproteins. The third and fourth common groups were proteins with dilsufide bonds (48 proteins) and acetylation sites (34 proteins). Lipoproteins, palmitoylated proteins, nitrated proteins, ubiquitinated proteins… contributed to a small fraction of proteins with modifications (Fig. 3) .
Discussions
In membrane proteomics, former studies are often inclined to use tissue/cell samples. Using membrane protein extraction by organic acid and NanoLC-MS/MS, Da Cruz et al found 182 membrane proteins from mouse liver mitochondrial inner membrane. 21 Another study used membrane proteins extraction from pancreatic cancer cells, SDS-PAGE, in-gel digestion and NanoLC-ESI-MS/MS and detected more than 200 proteins. 18 In addition, a large number (862) of membrane proteins were found in the brain cortex. 19 The difference in the number of detected membrane proteins from various tissue types can be due to the specificity of each tissue, as well as fractionation and enrichment methods of each study. Combining data from four different sources, an early survey of the plasma by Anderson et al found 212 proteins with at least one TMD with multiple origins, 1 which is similar to our results. Probably, there might be more membrane proteins in the serum that have not been detected yet because of their low abundance compared to other serum proteins.
Phosphorylation and glycosylation are the two most common modifications of protein in animal cells. Phosphorylation modifies the structure and function of many proteins. An upset balance between phosphorylation and dephosphorylation is the cause of many diseases. 22 Glycosylation was estimated to be found in over 50% of human proteins, 23 and also of interest because some diseases were found to be related to glycan structural alterations. 24, 25 Our results with the high proportion of phosphoproteins and glycoproteins showed the potential of membrane proteins in serum for diagnosis and treatment of disease.
conclusion By using NanoLC-ESI-MS/MS technologies and bioinformatics tools, a data set of 217 membrane proteins from normal human serum was identified. Some characterization such as subcellular distribution, molecular weigh, post translational modification, transmembrane domain (TMD) and average of hydrophobicity of the identified proteins were also given. 129 proteins (59%) have at least one transmembrane domain, and 187 proteins (86%) have post-translational modifications.
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